Neurocrine Biosciences (NBIX) Total Return Calculator
$10,000 since Dec 2007, with and without reinvesting · data through Oct 2026
$10,000 invested in Neurocrine Biosciences (NBIX) ten years ago, at the end of Oct 2016, was worth $33,379 at the end of Oct 2026 with every dividend reinvested: 12.8% a year, against $41,633 in the S&P 500. Since Dec 2007, $10,000 became $321,806 reinvested (20.2% a year), or $321,806 taking the dividends as cash, $0 of it paid out along the way.
NBIX became
$321,806
S&P 500: $72,756
Return a year
20.2%
S&P 500: 11.1%
Payouts reinvested
$0
bought more shares
Worst drop
-62.6%
S&P 500: -48.2%
$10,000, Dec 2007 to Oct 2026
Payouts reinvested · S&P 500 reinvested
| Year | NBIX total return | Paid out | S&P 500 |
|---|---|---|---|
| 2026 (part) | +3.0% | $0 | +11.7% |
| 2025 | +3.9% | $0 | +17.7% |
| 2024 | +3.6% | $0 | +24.9% |
| 2023 | +10.3% | $0 | +26.2% |
| 2022 | +40.2% | $0 | −18.2% |
| 2021 | −11.1% | $0 | +28.7% |
| 2020 | −10.8% | $0 | +18.3% |
| 2019 | +50.5% | $0 | +31.2% |
| 2018 | −8.0% | $0 | −4.6% |
| 2017 | +100.5% | $0 | +21.7% |
| 2016 | −31.6% | $0 | +12.0% |
| 2015 | +153.2% | $0 | +1.2% |
| 2014 | +139.2% | $0 | +13.5% |
| 2013 | +24.9% | $0 | +32.3% |
| 2012 | −12.0% | $0 | +16.0% |
| 2011 | +11.3% | $0 | +1.9% |
| 2010 | +180.9% | $0 | +15.1% |
| 2009 | −15.0% | $0 | +26.4% |
| 2008 | −29.5% | $0 | −36.8% |
"Paid out" is what your holding received that year. Month-end prices; no costs or taxes.
Key facts: NBIX total return
Data as of · Source: SmarterDividends data
- $10,000 invested in Neurocrine Biosciences (NBIX) at the end of Dec 2007, with dividends reinvested, was worth $321,806 at the end of Oct 2026: 20.2% a year, against $72,756 (11.1% a year) in the S&P 500.
- Over the 10 years to Oct 2026, NBIX turned $10,000 into $33,379 with dividends reinvested, 12.8% a year.
- Over the 5 years to Oct 2026, NBIX returned 6.7% a year with dividends reinvested (S&P 500: 12.0%).
- Taking NBIX's dividends as cash instead of reinvesting them, the same $10,000 ended at $321,806, including $0 of cash received; reinvesting added $0.
- NBIX's best calendar year in that time was 2010 (180.9%) and its worst 2016 (-31.6%), with dividends reinvested.
Cite this page
SmarterDividends, "Neurocrine Biosciences (NBIX) Total Return Calculator," updated Nov 22, 2026, https://smarterdividends.com/stocks/NBIX/total-return
NBIX total return questions
If I invested $10,000 in NBIX 10 years ago, how much would I have?
About $33,379 at the end of Oct 2026, with every dividend reinvested: 12.8% a year. Taking them as cash, you'd have shares worth $33,379 or so plus the cash you received. The same $10,000 in the S&P 500 became $41,633.
What is NBIX's total return since Dec 2007?
3118% in total, or 20.2% a year, through Oct 2026 with dividends reinvested. The share price alone rose 3118%.
How much of NBIX's return came from dividends?
About 0% of its yearly return since Dec 2007. Reinvesting them, rather than taking cash, left you $0 better off on a $10,000 start.
What was NBIX's worst year?
2016, at -31.6% with dividends reinvested (S&P 500: 12.0%). Its deepest fall from a peak, on month-end values, was -62.6%.
How is total return calculated here?
From month-end prices: the adjusted price counts every dividend reinvested in the month it was paid; the plain price doesn't. The S&P 500 is SPY with its dividends reinvested. No trading costs or taxes.
More on NBIX
